al., 2001; Smith et al., 2008). However, other drugs commonly used in patients with HIV/AIDS such as rifampin and trimethoprim/sulfamethoxazole can also cause pancreatitis. The committee found no current indicators that coinfection would prevent ability to work for a continuous period of 12 months or result in death.

2. The Consensus Committee shall produce a written report for the use of SSA analyzing documents received in response to SSA’s HIV Advance Notice of Proposed Rulemaking (ANPRM) request for public comment to determine which, if any, recommendations have the potential to become indicators of disability as defined by SSA (that is, to assess which, if any, comments or recommendations would be useful in developing listing criteria for determining disability).

Response: The committee considered all comments responding to SSA’s HIV ANPRM request. As discussed in Chapter 1, some of the responses were built on by the committee in the development of the report. For example, the committee recommended that HIV encephalopathy be broadened to include other neurocognitive conditions and added central nervous system lymphomas, both suggestions in response to the 2008 ANPRM. Other more specific responses (e.g., modifying “herpes zoster” to “herpes or varicella zoster”) were not seen to be as relevant to the report, given the current state of medical practice and the committee’s reconceptualization of the HIV Infection Listings.

3. The Consensus Committee shall produce a written report for the use of SSA that compares and contrasts findings in the most current medical literature and ANPRM public comments with SSA’s current HIV listings, as well as the key concepts included in the introduction of the HIV listings.

Response: The current 14.08 Listing consists, for the most part, of opportunistic infections. Many of these infections are proposed to be excluded from being named specifically in a revised listing because they are not as common or disabling as they once were, such as bacterial and protozoan or helminthic infections (see Table B-4). The committee believes that claimants who are at significant risk of being disabled (i.e., those who were once at high risk for acquiring an opportunistic infection) would have at least one of the following:

  • CD4 ≤ 50 cells/mm3;

  • Imminently fatal or severely disabling HIV-associated conditions;



The National Academies | 500 Fifth St. N.W. | Washington, D.C. 20001
Copyright © National Academy of Sciences. All rights reserved.
Terms of Use and Privacy Statement